{"id":535117,"date":"2021-09-07T16:09:14","date_gmt":"2021-09-07T20:09:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/"},"modified":"2021-09-07T16:09:14","modified_gmt":"2021-09-07T20:09:14","slug":"oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/","title":{"rendered":"Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">IRVINE, Calif., Sept.  07, 2021  (GLOBE NEWSWIRE) &#8212; Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, today announced that management will participate in one-on-one and group investor meetings at the 5<sup>th<\/sup> Annual Lake Street Capital Markets Best Ideas Growth Conference.<\/p>\n<p>\n        <strong>Conference Details:<\/strong>\n      <\/p>\n<p>\n        <strong>5<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Lake Street Capital Markets Best Ideas Growth Conference<\/strong><br \/>\n        <br \/>Date: Tuesday, September 14, 2021<br \/>Format: 1&#215;1 and Group Investor Meetings<\/p>\n<p>Investors interested in meeting with the Oncocyte management team during these events should contact their respective Lake Street Capital Markets representatives.<\/p>\n<p>\n        <strong>About Oncocyte Corporation<\/strong><br \/>\n        <br \/>Oncocyte is a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer. The Company, through its proprietary tests and pharmaceutical services business, aims to help save lives by accelerating the diagnosis of cancer and advancing cancer care. The Company\u2019s tests are designed to help provide clarity and confidence to physicians and their patients at every stage. DetermaRx\u2122 identifies early-stage lung cancer patients who are at high risk for cancer recurrence and who may benefit from adjuvant chemotherapy. DetermaIO\u2122, a gene expression test currently used as a research-use only tool, assesses the tumor microenvironment to predict response to immunotherapies. The Company\u2019s pipeline of tests in development also includes DetermaTx\u2122, which will assess mutational status of a tumor, blood-based monitoring test DetermaCNI\u2122, and long-term recurrence monitoring test DetermaMx\u2122. In addition, Oncocyte\u2019s pharmaceutical services provide companies that are developing new cancer treatments a full suite of molecular testing services to support the drug development process.<\/p>\n<p>DetermaRx\u2122, DetermaIO\u2122, DetermaTx\u2122, DetermaCNI\u2122 and DetermaMx\u2122 are trademarks of Oncocyte Corporation.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Bob Yedid<br \/>LifeSci Advisors, LLC<br \/>646-597-6989<br \/>bob@lifesciadvisors.com<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTU1MCM0MzkyOTM2IzUwMDA1MTg5MA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2RlMWY4YzYtYzg3NS00OTY4LWI1NTQtYjQ5MTVkNTI1MjEyLTUwMDA1MTg5MA==\/tiny\/Oncocyte-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>IRVINE, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, today announced that management will participate in one-on-one and group investor meetings at the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference. Conference Details: 5 th Annual Lake Street Capital Markets Best Ideas Growth Conference Date: Tuesday, September 14, 2021Format: 1&#215;1 and Group Investor Meetings Investors interested in meeting with the Oncocyte management team during these events should contact their respective Lake Street Capital Markets representatives. About Oncocyte Corporation Oncocyte is a precision diagnostics and monitoring company &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-535117","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, today announced that management will participate in one-on-one and group investor meetings at the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference. Conference Details: 5 th Annual Lake Street Capital Markets Best Ideas Growth Conference Date: Tuesday, September 14, 2021Format: 1&#215;1 and Group Investor Meetings Investors interested in meeting with the Oncocyte management team during these events should contact their respective Lake Street Capital Markets representatives. About Oncocyte Corporation Oncocyte is a precision diagnostics and monitoring company &hellip; Continue reading &quot;Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-07T20:09:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTU1MCM0MzkyOTM2IzUwMDA1MTg5MA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference\",\"datePublished\":\"2021-09-07T20:09:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\\\/\"},\"wordCount\":319,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTU1MCM0MzkyOTM2IzUwMDA1MTg5MA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\\\/\",\"name\":\"Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTU1MCM0MzkyOTM2IzUwMDA1MTg5MA==\",\"datePublished\":\"2021-09-07T20:09:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTU1MCM0MzkyOTM2IzUwMDA1MTg5MA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTU1MCM0MzkyOTM2IzUwMDA1MTg5MA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/","og_locale":"en_US","og_type":"article","og_title":"Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference - Market Newsdesk","og_description":"IRVINE, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, today announced that management will participate in one-on-one and group investor meetings at the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference. Conference Details: 5 th Annual Lake Street Capital Markets Best Ideas Growth Conference Date: Tuesday, September 14, 2021Format: 1&#215;1 and Group Investor Meetings Investors interested in meeting with the Oncocyte management team during these events should contact their respective Lake Street Capital Markets representatives. About Oncocyte Corporation Oncocyte is a precision diagnostics and monitoring company &hellip; Continue reading \"Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-07T20:09:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTU1MCM0MzkyOTM2IzUwMDA1MTg5MA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference","datePublished":"2021-09-07T20:09:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/"},"wordCount":319,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTU1MCM0MzkyOTM2IzUwMDA1MTg5MA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/","name":"Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTU1MCM0MzkyOTM2IzUwMDA1MTg5MA==","datePublished":"2021-09-07T20:09:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTU1MCM0MzkyOTM2IzUwMDA1MTg5MA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTU1MCM0MzkyOTM2IzUwMDA1MTg5MA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-the-5th-annual-lake-street-capital-markets-best-ideas-growth-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535117","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=535117"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535117\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=535117"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=535117"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=535117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}